Invention Grant
- Patent Title: HCK as a therapeutic target in MYD88 mutated diseases
-
Application No.: US15581736Application Date: 2017-04-28
-
Publication No.: US10525060B2Publication Date: 2020-01-07
- Inventor: Steven P. Treon , Guang Yang , Nathanael S. Gray , Sara Jean Buhrlage , Li Tan
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K45/06
Abstract:
Methods of treatment of conditions or diseases associated with myeloid differentiation primary response (MYD88) protein using a selective HCK inhibitor are provided herein.
Public/Granted literature
- US20170333436A1 HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES Public/Granted day:2017-11-23
Information query
IPC分类:
